Healthcare >> Analyst Interviews >> January 27, 2003

Venture Investing In Biotechnology: G.steven Burrill – Burrill & Co

G. STEVEN BURRILL is CEO of Burrill & Company, a San Francisco- based life sciences merchant bank. In 2002, Mr. Burrill was recognized as a biotech investment visionary by the prestigious Scientific American magazine (The Scientific American 50). He currently serves on six Boards of Directors, including DepoMed and Third Wave Technologies, and is Chairman of the Boards of Pyxis Genomics and Paradigm Genetics. Prior to founding Burrill & Company in 1994, he spent 28 years with Ernst & Young, directing and coordinating the firm's services to clients in the biotechnology/life sciences/high technology/manufacturing industries worldwide. Profile
TWST: May we start out with a quick overview of Burrill & Co.?

Mr. Burrill: We are a private merchant bank with 45 people

located in San Francisco. We are essentially a large